Sexual Health Assessment

Author PeaceHealth Laboratories Modified by 07.11.2022

We rely on polymerase chain reaction testing (PCR) for the most rapid, specific and sensitive testing available for HIV and HSV diagnosis. Our focus on clinically relevant targets means you get exactly the data you need to aid in diagnosis. Our extensive menu of women’s health test offerings makes adherence to national testing guidelines easy.

Disease	Testing Guidelines	PeaceHealth Laboratories Tests
Chlamydia	CDC: Routine screening of all sexually active women aged = 25 years Routine screening should occur whether or not patient is pregnant	68363 CT & GC, TMA Amplified 68360 CT, TMA Amplified
Gonorrhea	CDC: Screening recommended for all young, sexually active women, including those who are pregnant Those with individual or population risk factors should also be screened	68363 CT & GC, TMA Amplified 68362 GC, TMA Amplified
Cervical Cancer	ACOG: First cervical cancer screening at age 21 Screening every two years for women <30 Screening every three years for women >30	70072 ThinPrep Pap 70066 ThinPrep Pap with HPV* 70062 SurePath Pap 70091 SurePath Pap with HPV* *ThinPrep and SurePath testing for HPV >/+ 30 yr, HPV if ASCUS, and HPV if abnormal also available.
HIV	U.S. Preventive Services Task Force: Routine screening for all adolescents and adults at increased risk for HIV infection All pregnant women should be screened for HIV	42040 HIV-1 RNA PCR, Ultra Sensitive 3 42000 HIV 1 and 2 Antibodies; Reflex by Western Blot 42156 HIV-1 Antibody, Rapid; Reflex by Western Blot 97250 HIV, Western Blot
HSV	U.S. Preventive Services Task Force: Patients who are clinically symptomatic	58490 HSV by Real-Time Polymerase Chain Reaction (PCR) 58481 HSV 1 & 2 Antibodies, IgG & IgM 58462 HSV 1 Glycoprotein G-Specific, IgG 58464 HSV 2 Glycoprotein G-Specific, IgG 58471 HSV 1 & 2 Antibodies, IgM